GLP-1 Users Face Harsher Judgment in 1,313-Person Weight-Loss Study

2 articles · Updated · Newsweek · Aug 15

A 2026 randomized study of 1,313 participants found people described as losing weight with a GLP-1 were judged more negatively than those using diet and exercise, with some respondents even less willing to associate with them.
That stigma centered on whether weight loss was "earned": a separate 2026 experiment of 402 women measured beliefs that GLP-1 users had "taken the easy way out," while a JAMA Network Open study found patients anticipating or experiencing similar judgment.
User responses described sharply different disclosure strategies rather than a clear gender split—some openly shared losses of 144 or 155 pounds, while others hid medication use from friends or family to avoid being seen as vain, lazy or cheating.
Psychologist Rachel Goldman said privacy should not be confused with shame, drawing a line between keeping medical information private and feeling unable to disclose it because of social pressure.
The report concludes evidence still does not show women conceal GLP-1 use more than men; the clearer pattern is a broader cultural double standard that stigmatizes both obesity and medication-assisted weight loss.